Indofarma (Persero) Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Indofarma (Persero) Tbk PT with three other
pharmaceutical manufacturers in Asia:
Natco Pharma Limited
sales of 8.25 billion Indian Rupees [US$121.23 million]
of which 52%
was Finished Dosage Formulations),
Bukwang Pharmaceutical Company Limited
of South Korea
(142.13 billion Korean Won [US$120.95 million]
of which 100%
was Pharmacy), and
Jacobson Pharma Corporation Ltd
based in Hong Kong
(947.59 million Hong Kong Dollars [US$122.16 million]
of which 89%
was Generic drugs).
During the year ended December of 2015, sales at
Indofarma (Persero) Tbk PT were 1.62 trillion Indonesian Rupiahs (US$120.99 million).
increase of 17.4%
versus 2014, when the company's sales were 1.38 trillion Indonesian Rupiahs.
This was the third consecutive year of growth at Indofarma (Persero) Tbk PT.